Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma
- 18 February 2014
- journal article
- Published by Elsevier
- Vol. 89 (1) , 77-83
- https://doi.org/10.1016/s0090-8258(02)00154-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Value of Thymidine Kinase in Patients with Cervical CarcinomaOncology, 2001
- Profile of Circulating Levels of Interleukin-1 Receptor Antagonist and Interleukin-6 in Colorectal Cancer PatientsScandinavian Journal of Gastroenterology, 1999
- Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor AntagonistInternational Reviews of Immunology, 1998
- Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist.The Journal of Experimental Medicine, 1995
- High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's diseaseThe Lancet, 1992
- A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemiaBritish Journal of Haematology, 1992
- Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.Journal of Clinical Investigation, 1991
- Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancerGynecologic Oncology, 1991
- Interleukin-1 and Its Biologically Related CytokinesPublished by Elsevier ,1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970